Scribe Therapeutics annual operating margin
2024
2025
Scribe Therapeutics Operating Margin Growth & History (SCTX)
Scribe Therapeutics's operating margin was −50.94% for fiscal 2025.
View full Scribe Therapeutics company overviewScribe Therapeutics annual operating margin history
| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −50.94% | +105.29 pp |
| 2024 | 2024-12-31 | −156.24% | — |
Scribe Therapeutics quarterly operating margin
Q1.25
Q2.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | −489.83% | −252.45 pp |
| Q1 2026 | 2026-03-31 | −556.52% | −524.07 pp |
| Q2 2025 | 2025-06-30 | −237.38% | — |
| Q1 2025 | 2025-03-31 | −32.45% | — |
Scribe Therapeutics operating margin trends
Between the periods ended 2024-12-31 and 2025-12-31, Scribe Therapeutics's operating margin increased from −156.24% to −50.94%, a change of +105.29 percentage points. The latest reported quarter, Q2 2026, shows −489.83%.
About the metric
What operating margin means
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
Calculation and source
How operating margin is calculated
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Scribe Therapeutics source filings ↗